Kaletra 80 mg/mL (Lopinavir and Ritonavir SOLUTION) 80 mg/mL

Kaletra 80 mg/mL is an oral solution containing lopinavir and ritonavir, used in HIV treatment. This medication combines two antiretroviral drugs to manage HIV infection.

Strength

80 mg/mL

Pack Size

1 BOTTLE in 1 CARTON (0074-3956-46) / 160 mL in 1 BOTTLE

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kaletra 80 mg/mL is primarily used in the treatment of HIV infection. It contains lopinavir and ritonavir, which work together to reduce the amount of HIV in the body. This solution is often prescribed as part of a broader antiretroviral therapy regimen to help control the virus and improve immune function. Patients may wonder, 'What is Kaletra used for?' and the answer is that it is designed to manage HIV and prevent its progression.

Side Effects

Common effects of Kaletra 80 mg/mL may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience changes in taste or mild headaches. These effects can vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Kaletra 80 mg/mL should be handled with care, especially regarding storage and administration. It is important to follow the prescribed dosage and instructions provided by a healthcare professional. This medication may interact with other drugs, so it is crucial to discuss all current medications with a doctor before starting treatment.

Avoid Interactions

Kaletra 80 mg/mL may interact with a variety of medications, including those metabolized by the liver's cytochrome P450 system. It is important to avoid alcohol while using this medication, as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to prevent potential interactions.

Frequently Asked Questions

Kaletra 80 mg/mL is used in the treatment of HIV infection as part of a combination antiretroviral therapy regimen.

Kaletra 80 mg/mL is an oral solution that should be taken as directed by a healthcare provider, typically with food to enhance absorption.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, and changes in taste.

Kaletra 80 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of Kaletra 80 mg/mL should be monitored by a healthcare provider to ensure its continued safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.